The history of Sildenafil presents a interesting case for stakeholders in the medicinal sector. While initially a phenomenal success, generating billions, the patent expiration and the subsequent flood of off-brand competitors have significantly changed revenue. This raises questions about the future viability of analogous therapeutic developmen… Read More